ODDB.org: Open Drug Database | Drugs

Mepha Pharma AG - Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/12,5 mg, Filmtabletten

Swissmedic Registration	67602	Sequence	02
Product name	Olmesartan-Amlodipin-HCT-Mepha 40 mg/5 mg/12,5 mg	Description	Filmtabletten
ATC-Classification	C09DX03	ATC-Description	Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
Introduction of Sequence	11.08.2020

Composition

Filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 38 mg, crospovidonum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, E 172 (flavum), macrogolum 4000, talcum, pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose	additional_information
Amlodipine	5 mg
Hydrochlorothiazide	12.5 mg
	40 mg	Filmtablette

BAG: Active Agent	Dose
Amlodipine	5 mg
Hydrochlorothiazide	12.5 mg
Olmesartan Medoxomil	40 mg

Inactive agents	Dose	additional_information




		color.
		color.
Lactose Monohydrate	38 mg
Macrogol	4000

		Überzug
	30

Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	28	19.69	37.85	B	SL	No
004	98	56.67	78.05	B	SL	No

2025	©ywesee GmbH